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Objectives. The aim of this study was to characterize the lesions of necrotizing gingivitis (NG) and necrotizing periodontitis (NP)
with regard to extent and severity, and to correlate these parameters with the host HIV serostatus, CD4+ T-cell count, neutrophil
count,age,andgender.Methods.Eighty-fourconsecutivepatients,39blackfemalesand45blackmalesaged20–46years,diagnosed
with NG/NP were recruited to the study over a period of two years. Results. For both HIV-seropositive and -seronegative patients,
the mandibular anterior gingiva was most frequently aﬀected; 74% had NG/NP aﬀecting ≥5 gingival tooth sites. Ninety percent
of all patients had a mean severity of ≤4 mm. There was no statistically signiﬁcant association between either extent or severity
of NG/NP and HIV serostatus, CD4+ T-cell count, neutrophil count, age, or gender. The diﬀerence between the number of HIV-
seropositive patients with NG/NP who had CD4+ T-cell counts ≤200 cells/mm3 and those who had CD4+ T cell counts of 201–
499 cells/mm3 was not statistically signiﬁcant. Conclusion. The clinical signs of NG/NP are similar in HIV-seropositive and -
seronegative patients, and are not related to CD4+ T-cell count, to neutrophil count, to gender, or to age.
1.Introduction
Necrotizing periodontal diseases, comprising necrotizing
gingivitis and necrotizing periodontitis, is a distinct disease
entity[1].In thispaperthe termsnecrotizing gingivitis (NG)
and necrotizing periodontitis (NP) are used in preference
to the usual terms necrotizing ulcerative gingivitis and
necrotizing ulcerative periodontitis. In NG the ulceration
is not a primary feature but is secondary to the marginal
gingival necrosis and in NP the necrosis aﬀects the peri-
odontal attachment apparatus, so the term ulceration is
inappropriate.
Necrotizing gingivitis is characterised by marginal gingi-
val necrosis starting at the tip of the interdental papilla, by
gingival bleeding and by pain with the subsidiary features
of pseudomembrane formation, cervical lymphadenopathy
and foetid breath [1–3]. Necrotizing periodontitis is not a
primary disease. It is an extension of the disease process into
the periodontal attachment apparatus. Necrotizing gingivitis
is common; NP is uncommon.
The pathogenesis of NG is multifactorial and involves
a complex interaction between infection of the gingiva by
periodontopathic bacteria, mainly spirochetes and fusiform
bacilli, a susceptible host, disease-modulating factors such
as immune suppression, malnutrition and other debilitating
conditions, and factors deregulating local immune responses
such as tobacco smoking, candida, and herpesviruses in the
dentogingival plaque [4–9].
Necrotizing gingivitis and NP are more frequent in
HIV-seropositive than in HIV-seronegative patients, but the
dentogingival periodontopathic microbial ﬂora, the clinical
manifestation, the course of the disease, and the response
to treatment in both groups are similar [7, 10]. Necrotizing
gingivitis is moreprevalentin HIV-seropositive patientswith
early HIV infection than in those with AIDS [11]a n dm a yb e
the ﬁrst clinical indicator of HIV infection [12].
The purpose of this study was to characterise the lesions
ofNG/NPwith regard to extent and severity, and to correlate
these parameters with the host HIV serostatus, CD4+ T-cell
count, neutrophil count, age and gender.2 AIDS Research and Treatment
2.MaterialandMethods
2.1. Subject Population. A p p r o v a lf o rt h i ss t u d yw a sg r a n t e d
by the Research and Ethics Committee of the University of
Limpopo, Medunsa Campus. Eighty-four patients from the
Ga-Rankuwa district in SouthAfrica diagnosed with NG/NP
in the Department of Periodontology and Oral Medicine
were recruited over a period of two years and the purpose of
the study was explained to them. There were 39 females and
45 males. All were black persons between the ages of 20 and
46 years and all were ofa similar socioeconomic status. None
ofthe participants knewtheir HIVserostatus, and none were
takingantiretroviral therapyatthetime ofNG/NPdiagnosis.
Ofthe 84 participants, 54 gaveinformed consentforHIV
testing. The HIV serostatus of these patients was determined
by enzyme-linked immunosorbent assay (ELISA) and West-
ern blot. CD4+ T-cell counts were determined for 55 of the
84 participants, and neutrophil counts for 52. CD4+ T-cell
counts were stratiﬁed into 3 groups: ≤200 cells/mm3, 201–
499 cells/mm3, ≥500 cells/mm3. Neutropenia was deﬁned
as a neutrophil count less than 2000 cells/mm3,a n dt h e
neutrophil counts were stratiﬁed into two groups: >2000
cells/mm3 (normal), and ≤2000 cells/mm3 (neutropenia).
The participants who agreed to be tested for HIV
infection were counselled by a designated health care worker
prior to the HIV testing and again when they were informed
of the results. Participants who were found to be HIV-
seropositive were referred immediately to the regional HIV
clinic for treatment.
2.2. Periodontal Health Status. In this study all cases of
NG/NP were diagnosed, and clinical information necessary
for this study was collected by a single specialist in Oral
MedicineandPeriodontology(NHW).Necrotizinggingivitis
was diagnosed by marginal gingival necrosis, gingival bleed-
ing and pain, and necrotizing periodontitis by extension
of this disease process into the periodontal attachment
apparatus [1].
Data recording was carried out as has been described
elsewhere [7], and each data set was given a unique
number for conﬁdentiality. Necrotizing gingivitis and NP
were grouped together. A single site of NG/NP was deﬁned
as the disease related to the buccal or palatal/lingual gingiva
of a single tooth. If an interdental papilla was involved, then
two sites would be recorded as being aﬀected.
Severityat any site was determined by measuring thever-
tical width of the visibly necrotic gingiva with a periodontal
probe. The severity was classiﬁed as being >4mmofgingival
necrosis or ≤4mm of gingival necrosis. The extent of the
lesions in any patient was classiﬁed according to the number
of gingival tooth sites aﬀected: those having ≥5N G / N Ps i t e s
and those with <5 NG/NP sites.
All patients received the standard treatment for NG/NP
as has been described previously [9, 12]: a 5-day course
of metronidazole 400mg 3 times per day, paracetamol
500mg 3 times per day, and chlorhexidine digluconate 0,2%
mouthwash twice daily, and after this 5-day regimen plaque
control instruction, scaling, and if necessary root planing
were carried out.
Table 1: Demographic data of the study population.
HIV positive HIV negative Unknown Total
Gender
Males 16 (19%) 8 (10%) 21 (25%) 45 (54%)
Females 27 (32%) 3 (4%) 9 (11%) 39 (46%)
Total 43 (51%) 11 (14%) 30 (36%) 84
(100%)
Smokers 027 9
Age
Mean 31 26 30 30
Standard
deviation 5.848 5.899 5.3 5.859
2.3. Statistical Analysis. All data were entered in Microsoft
Excel and all statistical analyses were performed on SAS,
running under Microsoft Windows Vista Business for a
personal computer. Analysis of variance (ANOVA), t-tests,
Fisher’s exact tests, and a logistic regression analysis were
performed. P values of <.05 were regarded as statistically
signiﬁcant.
3.Results
The demographic data of all participants are shown in
Table 1. There were 84 patients (mean age 30 years) with
NG/NP, 45 males (54%), and 39 females (46%). Nine of
the patients were tobacco smokers (11%). Thirty partici-
pants refused HIV testing (36%) and their HIV serostatus
remained unknown. Of the 54 participants who agreed to
be tested, 43 were HIV seropositive (80%) and 11 (20%)
were HIV-seronegative. The mean age of 26 years of the
HIV-seronegative patients with NG/NP was signiﬁcantly
lower than the mean age of 31 years of HIV-seropositive
patientswithNG/NP(pairwise t-tests, P = .05).OftheHIV-
seropositivegroupof43patientswithNG/NP,27werefemale
(63%) and 16 were male (37%) (Table 1).
Neutrophil counts were available for 52 patients; 36
(69%) had a normal neutrophil count and 16 (31%) had
neutropenia. The HIV serostatus was known only for 47
of these 52 patients: 37 were HIV-seropositive and 10-
seronegative. Ten of the 37 HIV seropositive patients (27%)
had neutropenia and 4 of the 10 HIV-seronegative patients
(40%) had neutropenia.
CD4+ T-cell counts were available for 55 of the patients,
for 49 of whom the HIV serostatus was known: 39 were HIV
seropositive and 10 were HIV seronegative (Table 2). There
wasnostatisticalsigniﬁcancebetweenthenumberofpatients
with CD4+ T-cell counts ≤200 cells/mm3 and the number
of patients with CD4+ T-cell counts of 201–499 cells/mm3
(Fischer’s exact test P = .16).
The mandibular anterior sextant was the most frequently
aﬀected sextant (Tables 3(a)-3(c)).
Data for frequency of tooth sites aﬀected were available
for 78 of the 84 patients. Fifty-eight patients (74%) had
NG/NP aﬀecting ≥5 tooth sites and 20 patients (26%) had
<5 tooth sites aﬀected (Table 4). There were statisticallyAIDS Research and Treatment 3
Table 2: The CD4+ T-cell counts of patients with NG/NP.
CD4+ T-cell count
HIV serostatus
≤200 201–499 ≥500 Total
No. of HIV- 24 10 5 39
seropositive patients
with NG/NP
No. of HIV-
seronegative patients — 1 9 10
with NG/NP
No. of patients
with NG/NP with 2 3 1 6
unknown HIV
serostatus
Total 26 14 15 55
Table 3
(a) The number of times speciﬁc sextants were aﬀected with NG/NP in
HIV-seropositive and -seronegative patients.
Sextant Upper right
posterior
Upper
anterior
Upper left
posterior
14 18 18
22 36 22
Sextant Lower right
posterior
Lower
anterior
Lower left
posterior
(b) The number of times speciﬁc sextants were aﬀected with NG/NP in
HIV-seropositive patients.
Sextant Upper right
posterior
Upper
anterior
Upper left
posterior
10 15 16
21 30 20
Sextant Lower right
posterior
Lower
anterior
Lower left
posterior
(c) The number of times speciﬁc sextants were aﬀected with NG/NP in
HIV-seronegative patients.
Sextant Upper right
posterior
Upper
anterior
Upper left
posterior
432
162
Sextant Lower right
posterior
Lower
anterior
Lower left
posterior
signiﬁcantly more HIV-seropositive patients with ≥5 tooth
sites aﬀected than there were with <5 tooth sites aﬀected (z-
test, P<.05).There was an equalnumber of HIV-seronegative
patients with NG/NP to the extent of ≥5 tooth sites and <5
tooth sites aﬀected (Table 4).
When evaluating all 776 NG/NP tooth site lesions in
all HIV-seropositive patients, HIV-seronegative patients, and
those with unknown HIV serostatus together, 87 individual
tooth site lesions (11.3%) had a severity of >4mm and 689
(88.77%)aseverityof ≤4mm. This sametrendwas observed
when the severity of all NG/NP sites was evaluated for the 38
HIV-seropositive patients in whom 8% of tooth site lesions
(31/402) were >4mm, and 92% (371/402) were ≤4mm.
Therewasnostatisticallysigniﬁcantrelationshipbetween
eitherextent orseverityontheonehand,andHIVserostatus,
CD4+ T-cell count, neutrophil count, age, or gender on the
other (logistical regression analysis).
4.Discussion
Necrotizing gingivitis is a disease of young adults and rarely
occurs before adolescence [13]. In this study the mean age
of the participants was 30 years. The mean age of the HIV-
seropositive patients with NG/NP (31 years) was statistically
signiﬁcantly higher than that of HIV-seronegative patients
(26) with NG/NP (pairwise t-test, P = .05) (Table 1). This
ﬁnding is diﬃcult to explain.
In our study, as in previously published data [7], in both
HIV-seropositive and -seronegative patients the gingiva of
the mandibularanterior sextant was most frequentlyaﬀected
by NG/NP(Tables 3(a)-3(c)).Forboth HIV-seropositiveand
-seronegative groups, there were more patients in whom
NG/NP aﬀected ≥5 tooth sites than <5 tooth sites, but there
were equal numbers of HIV-seropositive patients who had
<5a n d≥5 tooth sites aﬀected (Table 4). There were more
NG/NP lesions which had a severity of ≤4mmthan>4mm
(Table 4). For both extent and severity, these ﬁndings are in
line with other reported data [14].
With current knowledge of the aetiopathogenesis of
N G / N P ,t h et i s s u en e c r o s i si nN G / N Pc a n n o tb ee x p l a i n e d ,
nor can it be explained why the gingiva of anterior mandibu-
la rt eethi sm os ta ﬀected,orwhy insome patientstheNG/NP
is widespread while in other patients it is conﬁned to only a
few teeth.
A number of studies have shown that NG/NP is more
prevalent in HIV-seropositive than in HIV-seronegative
immunocompetent patients [11]. There are several reasons
for this diﬀerence. Firstly, HIV-induced systemic immune
suppression and HIV-associated malnutrition may lead to
increased susceptibility to NG/NP [9]. Secondly, the den-
togingival plaque of HIV-seropositive patients is known to
harbour herpesviruses and candida species that can con-
tribute to deregulation of local immune and inﬂammatory
responses, thus promoting the development of NG/NP [9,
15, 16].
It is possible that HIV-associated cytokine dysregula-
tion and qualitative defects of neutrophils, macrophages
and Langerhans cells in the gingival tissues may play an
important role in the pathogenesis of NG/NP and may
be responsible for the increased frequency of this disease
in HIV-seropositive patients compared to HIV-seronegative
patients.
Our case series comprised patients with NG/NP none
of whom knew their own HIV serostatus. Despite the fact
that 80% of those who consented to HIV testing were
found to be HIV seropositive which is certainly a striking
observation, the design of our study does not permit us to
draw any conclusions from this regarding NG/NP being an
indicator for HIV infection in patients with unknown HIV4 AIDS Research and Treatment
Table 4: The severity and extent of NG/NP in relation to the patients’ HIV serostatus.
Severity Extent (gingival tooth sites) Not documented
No. of HIV status ≤4mm >4mm <5 ≥5
patients Positive 46 2 10 28 5
with Negative 8 2 5 5 1
NG/NP Unknown 26 4 5 25 0
Total 70 8 20 58 6
serostatus. However, the prudent clinician will be advised by
this observation.
There was no statistically signiﬁcant diﬀerence between
the number of HIV-seropositive patients with NG/NP with
CD4+ T-cell counts of ≤200 cells/mm3 and the number
of those with CD4+ T-cell counts of 201–499 cells/mm3
(P = .34). Neutrophil counts were available for 52 patients:
neutrophil counts of 36 patients (69%) were within the
normal range, and 16 patients (31%) were neutropenic.
There was no statistically signiﬁcant association between
extent or severity of NG/NP on the one hand, and age,
gender, HIV serostatus, CD4+ T-cell count, or neutrophil
count on the other.
Thirty of the total of 84 participants (36%) refused to
be tested for HIV infection (Table 1) in spite of having been
informed about the reported association between NG/NP
and HIV infection. Although antiretroviral treatment is
available and aﬀordable in the Ga-Rankuwa area in South
Africa many patients chose not to be tested even after
counselling by a healthcare professional. This could possibly
bebecause ofa perceivedstigma related toHIVinfectionand
fear of being shunned by their communities. The social and
health concerns arising from this are diﬃcult to address.
The treatment protocol that we advocate has proved in
practice to be successful in both HIV-seropositive and -
seronegative patients [9, 12, 14]. It avoids the discomfort
and messiness of scaling and root planing in the presence of
extensive acute gingival inﬂammation, and it is less liable to
result in loss of periodontal attachment.
Once the inﬂammation and acute pain of NG have been
controlled with systemic metronidazole, further manage-
ment of the gingival condition becomes much easier for the
dentist and less intimidating for the patient.
In our study, for logistical reasons related to long
distances and patient ﬁnances, patient recall information
was incomplete, or in the case of follow-up information
obtained by telephone, probably unreliable. It was therefore
not possible to draw any statistically valid conclusions as to
the rate of recurrence. However, what information could be
obtained suggests that the rate of recurrence was low.
5.Conclusion
Necrotizing gingivitis and necrotizing periodontitis more
frequently aﬀect the anterior mandibular gingiva than other
sextants. NG/NP generally aﬀects the gingiva of ≥5 teeth
and typically each aﬀected site has ≤4mm of necrotic
gingiva.Theclinicalsigns aresimilar inHIV-seropositiveand
-seronegative patients, and are not related to CD4+ T-cell
count, to neutrophil count, to gender, or to age.
The mean age of HIV seronegative patients with NG/NP
is statistically higher than that of HIV-seropositive patients
with NG/NP, but there is no statistically signiﬁcant asso-
ciation between extent or severity of NG/NP on the one
hand, and age, gender, HIV-serostatus, CD4+ T-cell count,
or neutrophil count on the other.
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